MG-ADL: still a relevant outcome measure

Area of Science:

• Neurology
• Clinical Assessment
• Myasthenia Gravis Research

Background:

• Myasthenia Gravis (MG) poses challenges in daily activities.
• Validating outcome measures is crucial for assessing MG progression and treatment efficacy.
• The Myasthenia Gravis-specific Activities of Daily Living (MG-ADL) scale requires performance evaluation.

Purpose of the Study:

• To assess the performance and validity of the MG-ADL scale.
• To determine the correlation of MG-ADL with other established MG outcome measures.
• To identify a clinically meaningful change score for the MG-ADL.

Main Methods:

• A multicenter study involving consecutive MG patients.
• Assessment using MG-ADL, MG Composite (MGC), and MG 15-item Quality of Life (MG-QOL15) scales.
• Statistical analysis included descriptive statistics, Pearson correlation, and test-retest reliability.

Main Results:

• Strong positive correlations were observed between MG-ADL and MGC (r=0.85) and MG-QOL15 (r=0.76).
• Correlation between delta MG-ADL and physician impression of change was strong (r=0.70).
• A 2-point improvement in MG-ADL was the best predictor of clinical improvement, with high test-retest reliability.

Conclusions:

• The MG-ADL scale demonstrates strong correlation with validated MG outcome measures.
• A 2-point improvement on the MG-ADL scale indicates clinical improvement in MG patients.
• The MG-ADL is a valuable tool for both MG research and routine clinical practice.